Dutch health insurer VGZ, on Monday announced that it has invested €6M in NLC Health Ventures (NLC), which is dedicated to supporting early-stage healthcare innovations.
This investment marks the first time a health insurer has invested in NLC.
With this move, VGZ and NLC enter into a strategic partnership to develop and grow impactful, innovative companies in healthcare.
This capital injection will enable NLC to expand to numerous startups each year.
Since 2015, NLC has been bringing impactful innovations to patients on a large scale, with over 100 startups, 4 funds, and activities in 16 countries, all aimed at improving the quality of healthcare.
One such example is Nicolab.
Nicolab significantly improves time-sensitive stroke treatments through AI-supported information exchange between doctors and hospitals.
With this innovation, patients have a better chance of emergency treatment to remove risky clots and are 1.8 times more likely to live independently after a stroke.
This leads to a better quality of life and significant cost savings for hospitals and society.
NLC played a key role in making Nicolab’s stroke care solution available.
NLC Health Ventures: Active health technology investor
Based out of Amsterdam, NLC Health Ventures is the most active health technology investor in Europe and the world’s largest healthtech venture builder.
NLC finds, builds, and scales transformative health innovations to provide more patients with quality care.
NLC is ‘BCorp,’ its funds comply with SFDR9 guidelines, and they contribute to ESG 3, 9, and 17.
“VGZ sees major challenges in healthcare, for which NLC can find suitable innovations, from around the world and build them into full-fledged companies. The investment from and cooperation with VGZ will make it possible to get these innovations to patients faster,” said Bert-Arjan Millenaar, CEO and founder of NLC Health Ventures.
VGZ: A driver of healthcare innovation
VGZ is dedicated to contributing to the future of healthcare and aims to be a leader in sustainable investment. The “Voorop in Zorg” fund is part of Coöperatie VGZ.
The fund invests 60 million in innovative companies that focus on keeping healthcare accessible and affordable.
It primarily targets (pre)seed and early-stage companies involved in Medtech, Healthtech, Digital Health Services, and data exchange.
In addition to providing early-stage capital, VGZ also utilises its healthcare knowledge and expertise to expedite the development of these companies, with the shared ambition of enhancing healthcare.
Kees Hamster, CFO of VGZ says, “VGZ can leverage its knowledge and expertise to help companies that are about to enter the market or are in the process of further scaling up in the Netherlands, by offering access to know-how on reimbursements, market size, current care pathways, contracting, and revenue models.”
Read the orginal article: https://siliconcanals.com/news/startups/vgz-invests-6m-in-nlc-health-ventures/
